|
Mr. Dariani has significant experience as an entrepreneurial business leader with a strong background in technology development. Prior to joining Semorex, he was President and co-founder of Focus Pharmaceuticals, Inc., a specialty private pharmaceutical company, where he managed and guided the development and approval of drug products, achieving one FDA approval and bringing another to the clinical evaluation stage. He successfully sold Focus in February of 2003. Prior to Focus, Mr. Dariani was Vice President of the chiral pharmaceutical business unit at Celgene Corporation where he was responsible for the successful development of the chirally pure version of Ritalin (including formulation development and manufacturing, preclinical development, clinical development, and regulatory approval). Mr. Dariani brings together an entrepreneurial capability, strong project management skills, an excellent foundation in science and engineering and most importantly a sound grasp of strategies and business. | 